Alessio Maria M

Show results for

Unknown (12)
Proteomics (3)
Transcriptomics (2)
Metabolomics (2)

Organisms

Homo sapiens (2)

Repository

MassIVE (3)
biostudies-arrayexpress (2)
MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Impact (2)
LTQ Orbitrap Velos (2)
LTQ Orbitrap XL (2)
MaXis 4G (2)
Orbitrap Fusion (2)
Synapt G2-S HDMS (2)
TripleTOF 5600 (2)
Q Exactive (2)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2017 (3)
2022 (2)
2015 (1)
2013 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:15611 (2)
CHEBI:15698 (2)
CHEBI:15728 (2)
CHEBI:15891 (2)
CHEBI:15978 (2)
CHEBI:15999 (2)
CHEBI:16020 (2)
CHEBI:16199 (2)
CHEBI:16335 (2)
CHEBI:16359 (2)
CHEBI:16450 (2)
CHEBI:16530 (2)
CHEBI:16628 (2)
CHEBI:16668 (2)
CHEBI:16675 (2)
CHEBI:16704 (2)
CHEBI:16708 (2)
CHEBI:16737 (2)
CHEBI:16750 (2)
CHEBI:16827 (2)
CHEBI:16919 (2)
CHEBI:17012 (2)
CHEBI:17050 (2)
CHEBI:17140 (2)
CHEBI:17154 (2)
CHEBI:17172 (2)
CHEBI:172453 (2)
CHEBI:17287 (2)
CHEBI:17385 (2)

Metabolite Name

O-Tyrosine (2)
(R)-3-hydroxybutyrylcarnitine (1)
1,11-Undecanedicarboxylic acid (1)
1,3-Dimethyluric acid (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)* (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (1)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (1)
1-arachidonoyl-GPI (20:4)* (1)
1-lignoceroyl-GPC (24:0) (1)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)* (1)
1-linoleoyl-GPC (18:2) (1)
1-linoleoyl-GPE (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylguanidine (1)
1-methylhistamine (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* (1)
1-oleoyl-GPI (18:1) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (1)
1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) (1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) (1)
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* (1)

Study type

Transcription profiling by array (1)
Methylation profiling by array (1)

Release Date

2025 (3)
2022 (2)
2020 (2)
2014 (2)
2015 (1)
2013 (1)
2026 (1)
2024 (1)
2023 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Treatment of gastric cancer.

Not available

S-EPMC3930964 | biostudies-literature

Clinical management of advanced gastric cancer: the role of new molecular drugs.

Not available

S-EPMC4209522 | biostudies-literature

Conservative two-stage revision with primary components of infected total hip arthroplasty: An analysis of survival, clinical and radiographic outcomes.

Not available

S-EPMC7529346 | biostudies-literature

The impact of depression, anxiety and stress on self-care in inflammatory bowel disease: a systematic review.

Not available

S-EPMC12850693 | biostudies-literature

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Xenograft assays)

Glioblastoma (GBM) is a common and deadly form of brain tumor in adults. Dysregulated metabolism in GBM offers an opportunity to deploy metabolic interventions as precise therapeutic strategies. To identify the molecular drivers and the modalities by which different molecular subgroups of GBM exp...

2022-11-08 | MTBLS730 | MetaboLights

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Stem cell and cell line assays)

2022-11-08 | MTBLS4708 | MetaboLights

Standardization of mitochondrial proteomics

Comparison of the extraction performances of three different mitochondria enrichment protocols (differential centrifugation, sucrose gradient, a commercial kit based on surfactants) on ten different cell lines. Samples were analysed on several instrumental platforms. Mitochondrial pellets were lysed...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2017-05-30 | MSV000081121 | MassIVE

Standardization of mitochondrial proteomics v2 NP

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2017-07-14 | MSV000081329 | MassIVE

Identification of a DNA methylation signature in blood from subjects affected by Down syndrome

Down syndrome is characterized by a wide spectrum of clinical signs, which include cognitive and endocrine disorders and haematological abnormalities. Although it is well established that the causative defect of Down syndrome is the trisomy of chromosome 21, the molecular bases of Down syndrome phen...

ORGANISM(S): Homo sapiens

2015-03-03 | E-GEOD-52588 | biostudies-arrayexpress

Effect of erythropoietin on primed leukocyte expression profile

Resistance to erythropoietin (EPO) treatment is observed in a considerable proportion of anemic patients with chronic kidney disease. Previous reports suggest that inflammation is one of the major independent predictors of this resistance, and pro-inflammatory cytokines have been shown to inhibit er...

ORGANISM(S): Homo sapiens

2013-12-19 | E-GEOD-53336 | biostudies-arrayexpress

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

19 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets